ATYR
aTyr Pharma, Inc.
0.2783$
-1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | +95.7% | -21.7% | +5,500.7% | -97.7% | -21.7% | +1,287.2% | – | – | – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | -100.0% | – | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.7% | -6.9% | -4.0% | +44.8% | +68.4% | +8.3% | -22.4% | +69.5% | -59.0% | +89.2% | -50.3% | +1.3% | +3,051.5% | -96.9% | +1.0% | +5,618.3% | -98.2% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +95.7% | -21.7% | +5,500.7% | -97.7% | -21.7% | +1,287.2% | – | – | – | – | – | – | – | – | -107.8% | – | – | – | – | -263.0% | – | – | – | – | – | – | – | – | – | |
| – | -12.0% | +0.7% | -8.5% | -15.3% | -25.6% | +15.8% | +5.4% | -35.2% | -15.5% | -5.7% | -0.9% | +14.6% | -5.5% | +0.7% | +20.6% | +5.8% | +1.8% | -3.9% | +69.5% | -32.9% | +15.9% | +49.4% | +2.7% | +8.0% | +51.1% | -37.1% | +4.9% | +4.9% | +23.6% | +4.8% | +4.6% | +6.0% | -17.4% | -3.4% | +30.2% | +43.9% | -50.8% | -32.8% | -7.8% | – | |
| – | -2.5% | +18.4% | -13.0% | +5.9% | +59.4% | -30.9% | -14.6% | -28.8% | -2.5% | +4.9% | -4.4% | -22.2% | +33.6% | +2.9% | -17.1% | -4.8% | +12.3% | +17.0% | +3.9% | -7.2% | +3.7% | +29.7% | -0.9% | +5.1% | -5.5% | -0.5% | +9.1% | -28.8% | +21.0% | +9.5% | -4.7% | -0.2% | +7.7% | +10.2% | +24.5% | -2.5% | -18.7% | +5.5% | +0.3% | – | |
| – | -9.7% | +5.5% | -9.9% | -9.1% | +3.4% | -8.8% | -2.5% | -33.0% | -10.7% | -1.4% | -2.4% | -0.9% | +7.5% | +1.6% | +4.9% | +2.4% | +5.0% | +3.0% | +45.0% | -26.0% | +11.8% | +43.3% | +1.7% | +3.9% | +34.9% | -31.8% | +7.8% | -7.7% | +29.9% | +8.5% | +2.6% | +4.8% | -80.2% | +339.1% | +28.8% | -76.3% | +207.9% | -25.4% | -1.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -439.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -468.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -467.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -368.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.